In this part 2 with Rebecca Esparza, we resume discussing her Cancer journeys. 

Her first was an ovarian cancer, while her second was thyroid cancer.  

Rebecca’s tremendous faith, as well as her close family ties have helped her cope in dealing with these trying conditions.

Rebecca is a long time survivor and advocate, who has a tremendous desire to help others in their cancer journeys. 

Here are Rebecca’s links:
https://www.mdanderson.org/publications/annual-report/annual-report-2009/cancer-support-via-social-media.html

https://cdmrp.health.mil/cwg/stories/2018/rebecca_esparza_profile

NCCS Advocate Spotlight: Rebecca Esparza

Sharing Her Strength

Please join us for this inspirational interview!

#cancer #cancerjourney #cancerpatient #cancersurvivor #cancerlove #cancerfamily #cancerwarrior #cancereducation #cancerconqueringcommunity #positive #positivereinforcement #positiveaffirmations #2byourownhero #cancerconqueringcommunity

Most Recent Episodes

March 24, 2025

A Life Positively Transformed By Cancer

This is part 2 of my interviews with Mike Starks.  Honestly, I am extremely proud of Mike for what he has done as far as his cancer journey.  I love hearing about how his Relationships with his...

Watch Now

March 17, 2025

"You Literally Saved My Life!"

I had interviewed Mike Starks a couple of years ago after we met on Zoom.  I am so happy and honored to call Mike my friend.  Currently we both live in Texas.  Originally Mike had reached out...

Watch Now

March 10, 2025

An Ultra-Marathoner’s Cerebral Run With Cancer

Bill Thach has been battling cancer since 2018.  Last year, he decided to run an ultra marathon, 50 kilometers.  Bill is a firm believer that moving, running, and Exercise is a form of...

Watch Now

Load More Episodes

Mark Kageyama 2byourownhero

I am a stage 4 prostate, bone, and lung cancer patient/thriver. I have been battling cancer since early 2021. I have a Youtube channel called @2byourownhero. I always look to inspire people to appreciate their life, and appreciate their health.